Pulse Biosciences (PLSE) Receivables - Other (2020 - 2021)
Pulse Biosciences (PLSE) recorded quarterly Receivables - Other of $8.4 million in Q2 2021, up 584.46% quarter-over-quarter from $1.2 million in Q4 2020.
Pulse Biosciences (PLSE) Receivables - Other (2020 - 2021) Analysis & Trends
Pulse Biosciences' Receivables - Other history runs 2 years deep, the most recent figure standing at $8.4 million for Q2 2021.
- In Q2 2021, Receivables - Other changed N/A year-over-year to $8.4 million; the TTM figure through Jun 2021 stood at $8.4 million (changed N/A YoY), while the FY2020 annual figure was $1.2 million, changed N/A from the prior year.
- Receivables - Other was $8.4 million for Q2 2021 at Pulse Biosciences, up from $1.2 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $8.4 million in Q2 2021 to a low of $1.2 million in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Pulse Biosciences | 1.68 Bn | 1.68 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 8.37 Mn |
| Jun 30, 2021 | 8.37 Mn |
| Dec 31, 2020 | 1.22 Mn |
| Dec 31, 2020 | 1.22 Mn |